R&D
Central Research Institute
Nexpharm Korea's Central Research Institute consists of three main teams: the New Materials R&D Team, the Formulation Research Team, and the New Product Specification Setting Team.
We are building domestic and international networks to strengthen our R&D capabilities and efficiently manage resources,
thereby accelerating the development of new drugs with guaranteed economic feasibility.
Central Research Institute
the New Materials R&D Team, the Formulation Research Team, and the New Product Specification Setting Team.
Nexpharm Korea actively pursues investments and partnerships.
Nexpharm Korea has been investing and positive collaborations with Gyeonggi Bio Center, Gyeonggi Science and Technology Agency, Natural Products Drug Research Institute, Ulsan University Medical School to develop Next-generation source-based treatment, future prospective core technology, and continuous acquisition of new drug candidates.
